Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptor PD-1 (compound)
Most Correlated Studies
- Melanoma biopsies of patients pre anti-PD-1 therapy with Pembrolizumab
- CD4+ T cells from STAT1 and STAT3 KO response to IL-6 and IL-27 stimulation
- Melanoma tumor biopsies from patients treated with anti-PD1 therapy
- Splenic CD8+ T cells treated with anti-CD4 antibody post immunization with Ad5HVR48-Gag virus
- Cell Specific Expression in Trauma-Related Human T-Cell & Monocyte
Most Relevant Literature
- Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in pri…
- Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy.
- The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Tre…
- Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candida…
- When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma?
Most Relevant Clinical Trials
- Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participan…
- An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Pro…
- A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administe…
- Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced …
- A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (…
